Free Trial

Ingevity (NYSE:NGVT) Reaches New 1-Year Low After Analyst Downgrade

Ingevity logo with Basic Materials background

Ingevity Co. (NYSE:NGVT - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Thursday after StockNews.com downgraded the stock from a buy rating to a hold rating. The stock traded as low as $28.49 and last traded at $33.30, with a volume of 428135 shares changing hands. The stock had previously closed at $29.88.

Several other equities research analysts have also recently issued reports on NGVT. Wells Fargo & Company decreased their price target on shares of Ingevity from $45.00 to $32.00 and set an "equal weight" rating on the stock in a research note on Wednesday, April 9th. BMO Capital Markets upgraded shares of Ingevity from a "market perform" rating to an "outperform" rating and raised their target price for the stock from $62.00 to $65.00 in a research report on Wednesday, February 26th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $53.83.

Get Our Latest Report on NGVT

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of NGVT. GAMMA Investing LLC increased its position in Ingevity by 119.1% during the first quarter. GAMMA Investing LLC now owns 1,137 shares of the company's stock worth $45,000 after purchasing an additional 618 shares during the last quarter. NBC Securities Inc. increased its holdings in shares of Ingevity by 112,655.6% during the 1st quarter. NBC Securities Inc. now owns 10,148 shares of the company's stock worth $401,000 after buying an additional 10,139 shares during the last quarter. First Hawaiian Bank raised its position in shares of Ingevity by 19.6% in the 1st quarter. First Hawaiian Bank now owns 12,832 shares of the company's stock worth $508,000 after buying an additional 2,102 shares during the period. Wellington Management Group LLP boosted its holdings in Ingevity by 5.4% in the fourth quarter. Wellington Management Group LLP now owns 2,239,970 shares of the company's stock valued at $91,279,000 after acquiring an additional 115,581 shares during the last quarter. Finally, California State Teachers Retirement System grew its position in Ingevity by 3.7% during the fourth quarter. California State Teachers Retirement System now owns 33,993 shares of the company's stock valued at $1,385,000 after acquiring an additional 1,199 shares during the period. 91.59% of the stock is currently owned by hedge funds and other institutional investors.

Ingevity Price Performance

The company has a 50 day simple moving average of $41.70 and a 200 day simple moving average of $41.99. The company has a market capitalization of $1.16 billion, a price-to-earnings ratio of -2.69 and a beta of 1.54. The company has a quick ratio of 1.04, a current ratio of 1.87 and a debt-to-equity ratio of 6.86.

Ingevity (NYSE:NGVT - Get Free Report) last posted its earnings results on Tuesday, February 18th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.29 by $0.66. Ingevity had a negative net margin of 30.60% and a positive return on equity of 41.44%. The firm had revenue of $298.80 million during the quarter, compared to the consensus estimate of $297.40 million. As a group, research analysts predict that Ingevity Co. will post 4.45 EPS for the current year.

About Ingevity

(Get Free Report)

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.

Featured Stories

Should You Invest $1,000 in Ingevity Right Now?

Before you consider Ingevity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ingevity wasn't on the list.

While Ingevity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In
5 Stocks to BUY NOW in May 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines